Table III.
Univariate analysis of variables influencing recurrence in enrolled patients.
| Characteristics | No recurrence (n=37) | Recurrence (n=12) | P-value |
|---|---|---|---|
| Age (years) | 41.6±5.2 | 37.5±4.1 | 0.017a |
| Body mass index (kg/m2) | 23.1±2.7 | 22.1±4.1 | 0.302 |
| Menorrhagia | 0.315 | ||
| Yes, % (n) | 25% (2) | 53.8% (7) | |
| No, % (n) | 75% (6) | 46.2% (6) | |
| Gravidity | 2.1±1.0 | 2.4±1.1 | 0.393 |
| History of cesarean delivery | 0.999 | ||
| Yes, % (n) | 37.5% (3) | 7.7% (1) | |
| No, % (n) | 62.5% (5) | 92.3% (12) | |
| Preoperative serum cancer antigen 125 level (U/ml) | 69.0±54.3 | 115.8±51.0 | 0.012a |
| Pathological uterine size (cm3) | 135.4±84.0 | 164.5±70.1 | 0.285 |
| No of adenomyomas | 0.683 | ||
| Single, % (n) | 72.7% (16) | 27.3% (6) | |
| Multiple, % (n) | 77.8% (21) | 22.2% (6) | |
| Coexisting endometriosis | 0.363 | ||
| Yes, % (n) | 69.6% (16) | 30.4% (7) | |
| No, % (n) | 80.8% (21) | 19.2% (5) | |
| Accompanying uterine leiomyoma | 0.156 | ||
| Yes, % (n) | 92.9% (13) | 7.1% (1) | |
| No, % (n) | 68.6% (24) | 31.4% (11) | |
| Laparoscopic presacral neurectomy | 0.999 | ||
| Yes, % (n) | 75% (6) | 25% (2) | |
| No, % (n) | 75.6% (31) | 24.4% (10) | |
| Postoperative gonadotropin-releasing hormone agonist therapy | 0.025a | ||
| Yes, % (n) | 88.5% (23) | 11.5% (3) | |
| No, % (n) | 60.9% (14) | 39.1% (9) | |
| Postoperative levonorgestrel-releasing intrauterine system treatment | 0.190 | ||
| Yes, % (n) | 100% (8) | 0% (0) | |
| No, % (n) | 78.4% (29) | 21.6% (12) |
Data are presented as the mean ± standard deviation.
a
P<0.05.